News and Insights of 3D Printing and Manufacturing
CD3D Medical, the R&D arm of Polish 3D printing news provider CD3D Sp. z. o. o. (Centrum Druku 3D) has created an Open 3D Bioprinting Cluster in Lodz. Part of the Bionanopark laboratory complex, this facility, according to the company, is one of largest of its kind in Europe, housing 21 SKAFFOSYS 3D bioprinters developed specially for this purpose.
Engineers from McMaster University in Hamilton, Canada, have developed a 3D bioprinting method using magnets to rapidly produce cell clusters.
Researchers from the Massachusetts Institute of Technology (MIT) have used fine-scale 3D bioprinting and melt electrowriting to grow highly uniform cell cultures.
Poietis, a French biotechnology company, has announced the granting of a third patent for its laser-assisted 3D bioprinting method.
Readily3D, a manufacturer of volumetric 3D bioprinters, has announced its participation in the European ENLIGHT project.
In the intro to the HBO sci-fi series Westworld, a 3D printer churns out humanoid robots, delicately ...
Two postdoctoral researchers at UC Santa Barbara, Renxuan Xie and Sanjoy Mukherjee, developed the first 3D-printable “bottlebrush” elastomer. The new material results in printed objects that have unusual softness and elasticity that closely resemble those of human tissue. The researchers’ findings were published in the journal Science Advances.
Researchers at the University of Stuttgart and Robert Bosch Hospital are developing a novel 3D printed tissue platform that could replace animal testing in clinical trials.
Pandorum Technologies Pvt., a Bangalore-based biotechnology company, has used 3D bioprinted cornea tissue to promote scarless healing of wounds in the eye.
Canadian 3D bioprinting technology company Aspect Biosystems has announced its involvement in a $2.2 million project seeking to find new treatments for cancer. Starting this year, the company will be working with collaborators at two of the world’s largest pharmaceutical companies Merck and GSK, as well as McGill University’s Goodman Cancer Research Centre in Quebec.